Target
multikinase inhibitor
2 abstracts
Abstract
Salvage ipilimumab plus nivolumab in advanced hepatocellular carcinoma after prior anti-PD-(L)1 blockade.Org: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Johns Hopkins Hospital, University of Texas Southwestern Medical Center, Division of Digestive and Liver Diseases, The Ohio State University Comprehensive Cancer Center and Pelotonia Institute for Immuno-Oncology, Columbus, OH,
Abstract
Regorafenib plus tislelizumab for patients with metastatic colorectal cancer: A real-world study.Org: Affiliated Hospital of Jiangnan University, Wuxi, China,